Neuberg Diagnostics is reportedly planning a $350 million IPO next year, joining India's booming stock market. Founder GSK Velu also intends to list Trivitron Healthcare and Maxivision Eye Hospitals later. This move aligns with strong growth projections for India's diagnostics sector, driven by increasing chronic diseases and investor appetite.